2009 annual financial data
XTL Biopharmaceuticals 2009 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was 2,568,000 USD and net income was 2,587,000 USD.
Operating cash flow was -2,488,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- 2,568,000 USD
- Net income
- 2,587,000 USD
- Operating cash flow
- -2,488,000 USD